Back
Alnylam Pharmaceuticals Stock Price Chart

While Jobs Disappear, Phones Are Picking Up The Slack
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
32
ALNY
Alnylam Pharmaceuticals
Last Price:
$241.55
Seasonality Move:
0.38%
7 Day Trial
ALL ACCESS PASS
$
7

AI Is Changing Marketing Forever-Invest Before the Boom
Invest Now & Secure Your Stake in RAD Intel-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
Alnylam Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 244.56 | Sell |
20-day SMA: | 250.75 | Sell |
50-day SMA: | 254.23 | Sell |
200-day SMA: | 247.16 | Sell |
8-day EMA: | 244.3 | Sell |
20-day EMA: | 249.59 | Sell |
50-day EMA: | 253.97 | Sell |
200-day EMA: | 242.22 | Buy |
Alnylam Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.02 | Sell |
Relative Strength Index (14 RSI): | 43.46 | Sell |
Chaikin Money Flow: | -188438 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (242.34 - 268.96) | Sell |
Bollinger Bands (100): | (240.88 - 276.7) | Sell |
Alnylam Pharmaceuticals Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Alnylam Pharmaceuticals Stock
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 242.43 while ALNY 8-day simple moving average is 244.56, which is a Sell signal.
-
The stock price of ALNY is 242.43 while Alnylam Pharmaceuticals 20-day SMA is 250.75, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day simple moving average is 254.23 while ALNY share price is 242.43, making it a Sell technically.
-
ALNY stock price is 242.43 and Alnylam Pharmaceuticals 200-day simple moving average is 247.16, creating a Sell signal.
ALNY Technical Analysis vs Fundamental Analysis
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy or a Sell?
-
Alnylam Pharmaceuticals stock is rated a SellThe current Alnylam Pharmaceuticals [ALNY] share price is $242.43. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Alnylam Pharmaceuticals Stock Info
Market Cap:
31.4B
Price in USD:
242.43
Share Volume:
593.1K
Alnylam Pharmaceuticals 52-Week Range
52-Week High:
304.39
52-Week Low:
141.98
Sell
32
Alnylam Pharmaceuticals (ALNY)
is a Sell
Alnylam Pharmaceuticals Share Price Forecast
-
What is the Alnylam Pharmaceuticals stock price today?The Alnylam Pharmaceuticals stock price is 242.43 USD today.
-
Will ALNY stock go up or go down?Alnylam Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Alnylam Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Alnylam Pharmaceuticals is overvalued.
Is Alnylam Pharmaceuticals Stock a Buy?
-
Alnylam Pharmaceuticals share price is 242.43 while ALNY 8-day exponential moving average is 244.30, which is a Sell signal.
-
The stock price of ALNY is 242.43 while Alnylam Pharmaceuticals 20-day EMA is 249.59, which makes it a Sell.
-
Alnylam Pharmaceuticals 50-day exponential moving average is 253.97 while ALNY share price is 242.43, making it a Sell technically.
-
ALNY stock price is 242.43 and Alnylam Pharmaceuticals 200-day simple moving average is 242.22, creating a Buy signal.
Fundamental Analysis of Alnylam Pharmaceuticals
Is Alnylam Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.75 per share, an increase next quarter of $1.48 per share, an increase this year of $0.76 per share, and an increase next year of $2.81 per share.
Technical Analysis of Alnylam Pharmaceuticals
Should I short Alnylam Pharmaceuticals stock?
-
ALNY Moving Average Covergence Divergence (MACD) indicator is -5.02, suggesting Alnylam Pharmaceuticals is a Sell
-
Alnylam Pharmaceuticals Relative Strength Index (RSI) is 43.46, which suggest Alnylam Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Alnylam Pharmaceuticals is (242.34 - 268.96), which suggest Alnylam Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Alnylam Pharmaceuticals is (240.88 - 276.7), which suggest Alnylam Pharmaceuticals is a Sell
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.